Abstract | PURPOSE OF REVIEW: The spectrum of periodic fever syndromes (PFS)/autoinflammation diseases is continuously expanding. This review provides an overview of the primary research and an update on the main clinical developments in these disorders published in the past 12-18 months. RECENT FINDINGS: SUMMARY:
Caspase 1 activation and IL-1β release is central to the pathogenesis of many autoinflammatory syndromes. This is supported by the effectiveness of anti-IL-1 biologics in treatment of these disorders.
|
Authors | Sinisa Savic, Laura J Dickie, Michele Battellino, Michael F McDermott |
Journal | Current opinion in rheumatology
(Curr Opin Rheumatol)
Vol. 24
Issue 1
Pg. 103-12
(Jan 2012)
ISSN: 1531-6963 [Electronic] United States |
PMID | 22089100
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Interleukin-1beta
- Caspase 1
|
Topics |
- Caspase 1
(metabolism)
- Familial Mediterranean Fever
(drug therapy, etiology, metabolism)
- Humans
- Interleukin-1beta
(metabolism)
- Mevalonate Kinase Deficiency
(drug therapy, etiology, metabolism)
|